Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE:GMED) stock following the company's announcement of acquiring Nevro Corp . (NYSE:NVRO) for an equity value of ...

Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump ...

Shares of Great Easter Shipping Co., Godrej Consumer Projects Ltd., Jubilant Ingrevia Ltd. and Mahanagar Gas Ltd. will trade ...

Union Bank of India, Afcons Infrastructure Ltd. and Infosys Ltd. are some stocks that will be on the radar on Thursday. Union Bank's board approved to raise long-term bonds up to Rs 20,000 crore, and ...

Alterity Therapeutics (NASDAQ: ATHE) shares moved up at warp-speed Thursday, on announcing positive topline results from the ATH434-201 randomized, double-blind, placebo-controlled Phase 2 clinical ...

Galina Chernova, director of Globus, an NGO based in Atyrau ... The sea has always been our lifeline, but now we watch it disappear.” The environmental consequences are inseparable from the ...

You probably don’t think too much about eating. You pop something in your mouth, chew it up and swallow it. But, sometimes, what you eat may seem like it won’t go down, or it feels like it’s stuck in ...

“We do think Medtronic’s Mazor and Globus’ Excelsius can make a material difference.” Johnson & Johnson, Medtronic and Abbott were among the top companies to announce layoffs this year as the industry ...

Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...